Tech Company Financing Transactions

Qnovia Funding Round

Blue Ledge Capital, Evolution VC Partners and Gaingels participated in a $16 million Series B funding round for Qnovia. The funding round was announced on 12/10/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2920 West Broad St #243
Richmond, VA 23230
USA

Phone

(212) 741-5106

Website

www.qnovia.com

Email Address

[email protected]

Overview

Qnovia is a platform medtech and pharmaceutical company whose mission is to help save lives. We've created a novel inhaled drug delivery platform to effectively deliver a broad range of pharmaceuticals. Our disruptive drug delivery technology is more than a medical device; it is a technology platform with multiple applications that have the potential to affect the lives of billions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian Quigley

        

Chief Scientific Officer

Chris Cheng

        

Chief Technical Officer

Mario Danek

        

Co-Founder

Joe Walsh

        

Browse more venture capital transactions:

Prev: 12/10/2024: Stainless Software venture capital transaction
Next: 12/10/2024: MoldCo venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary